Jyske Bank
Share repurchase programme: Transactions of week 25 2025
Share repurchase programme: Transactions of week 25 2025
The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules").
The following transactions have been made under the program:
Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
Accumulated, previous announcement | 1,025.529 | 541.18 | 554,995,995 |
16 June 2025 | 15,000 | 636.39 | 9,545,919 |
17 June 2025 | 20,000 | 628.09 | 12,561,798 |
18 June 2025 | 19,892 | 627.82 | 12,488,633 |
19 June 2025 | 8,085 | 622.52 | 5,033,107 |
20 June 2025 | 13,479 | 625.81 | 8,435,235 |
Accumulated under the programme | 1,101.985 | 547.25 | 603,060,688 |
Following settlement of the transactions stated above, Jyske Bank will own a total of 1,101,985 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 1,79% of the share capital.
Attached to this corporate announcement, aggregated details on the transactions related to the share repurchase programme are shown by venue.
Yours faithfully,
Jyske Bank
Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi Winthrop Industrie25.6.2025 07:00:00 CEST | Press release
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Novartis Pharma AG25.6.2025 07:00:00 CEST | Press release
Novartis announces expiration of Regulus Therapeutics tender offer
Organizing Committee of the 7th Tourism Industry Development Conference in Heilongjiang Province25.6.2025 06:19:05 CEST | Press release
The Tourism Industry Development Conference in Heilongjiang Province Fuels High-quality Tourism Development
Giga Metals Corporation24.6.2025 22:29:34 CEST | Press release
Scott Lendrum appointed Chief Executive Officer of Giga Metals Corporation
Cellebrite DI Ltd24.6.2025 22:01:00 CEST | Press release
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom